AstraZeneca and Bristol-Myers Squibb Announce Top Line Results for SAVOR-TIMI-53 Cardiovascular Outcomes Trial of Onglyza (saxagliptin)
There are many products and supplements available on the market whose makers promise miraculous results
Inoda et al
[DOI] [PMC free article] [PubMed] [Google Scholar] 92.Stringham J.M., Garcia P.V., Smith P.A., Hiers P.L., McLin L.N., Kuyk T.K., Foutch B.K
This review aims to synthesize emerging evidence on how GSH depletion contributes to impaired immune and antioxidant activity in neurodegenerative diseases, such as Parkinsons Disease (PD), Alzheimers Disease (AD), and multiple sclerosis (MS)
These drugs mimic GLP-1, a hormone responsible for regulating appetite and food intake, leading to weight loss and improved control of blood sugar levels in people with Type 2 diabetes